Oral semaglutide vs orforglipron: what ORION’s indirect comparison tells clinicians and patients now
The ORION analysis from Novo Nordisk used population-adjusted indirect comparison methods to contrast oral semaglutide 25 mg tablets with Eli…
The ORION analysis from Novo Nordisk used population-adjusted indirect comparison methods to contrast oral semaglutide 25 mg tablets with Eli…
NIH scientists report a novel opioid, DFNZ, that in rodents produced sustained pain relief for over two hours while, unusually…
Clinical trial data show solriamfetol can modestly but reliably increase wakefulness in people with shift work disorder who start work…
Efzimfotase alfa, a next‑generation enzyme replacement therapy from AstraZeneca Rare Disease, produced a clear, statistically significant bone‑health signal in treatment‑naïve…
Novartis’ Phase III APPLAUSE‑IgAN trial published in the New England Journal of Medicine and presented at the 2026 World Congress…
New animal research from Baylor College of Medicine shows that metformin—at doses typically used in people—lowers blood glucose by suppressing…
New lab work from South Korea identifies microRNA‑93 (miR‑93) as a genetic driver of metabolic‑associated steatotic liver disease (MASLD) and…
Eli Lilly’s investigational triple agonist retatrutide produced large reductions in both A1C and body weight in TRANSCEND‑T2D‑1, a 537‑person Phase…
Two recent registry analyses from Sweden and Australia — together following nearly 100,000 adults, including more than 20,000 people who…
Lecanemab’s main action depends on its Fc fragment calling microglia into action: recent work from VIB and KU Leuven shows…
An NIH‑supported randomized trial of 140 pregnant adults with opioid use disorder found that weekly injectable extended‑release buprenorphine produced higher…
Melatonin can help some children—especially those with neurodevelopmental disorders or clear circadian shifts—but product variability, rising accidental exposures, and sparse…